St Bartholomew's Hospital, commonly known as Barts, is a teaching hospital located in the City of London. It was founded in 1123 and is currently run by Barts Health NHS Trust.

There are 387 beds in St Bartholomew's Hospital.

During the past decade, St Bartholomew's Hospital conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 65 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 45 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Bartholomew's Hospital" #1 sponsor was "Barts & The London NHS Trust" with 21 trials, followed by "University College, London" with 20 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Hoffmann-La Roche" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 239 different institutions and companies that sponsored additional 135 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Bartholomew's Hospital" #1 collaborator was "Cancer Research UK" with 20 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Barts & The London NHS Trust" with 5 trials as a collaborator, "British Heart Foundation" with 5 trials as a collaborator and "National Cancer Institute (NCI)" with 5 trials as a collaborator. Other collaborators include 215 different institutions and companies that were collaborators in the rest 182 trials.

According to Clinical.Site data, the most researched conditions in "St Bartholomew's Hospital" are "Lymphoma" (18 trials), "Breast Cancer" (12 trials), "Ovarian Cancer" (12 trials), "Prostate Cancer" (11 trials) and "Atrial Fibrillation" (9 trials). Many other conditions were trialed in "St Bartholomew's Hospital" in a lesser frequency.

Most popular intervention types in "St Bartholomew's Hospital" are "Drug" (212 trials), "Procedure" (56 trials), "Biological" (45 trials), "Device" (44 trials) and "Other" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "cisplatin" (15 trials), "cyclophosphamide" (13 trials), "etoposide" (12 trials) and "radiation therapy" (12 trials). Other intervention names were less common.

The vast majority of trials in "St Bartholomew's Hospital" are 267 trials for "All" genders, 31 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 92 active trials in "St Bartholomew's Hospital". 2 are not yet recruiting, 40 are recruiting, 48 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 144 completed trials in St Bartholomew's Hospital, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in St Bartholomew's Hospital, 19 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 48 trials that are defined as “Not Applicable".